join amble tirzepatide FDA Clarifies Compounding Rules as Supply Stabilizes 6 Weeks Weight Loss Update

A.BloomS

In March 2026, the FDA approved a higher strength of Semaglutide injection, 7.2 mg, sold under Wegovy HD, for certain adults who need additional weight reduction

There are already people in the Treasury thinking about the savings to the economy because of the opportunity to boost productivity

Degradation of heme in gram-negative bacteria: the product of the hemO gene of neisseriae is a heme oxygenase

News provided by University of Colorado Anschutz Jul 29, 2026, 00:00 ET A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)